Larvol Delta - BioSig-to-Host-Conference-Call-on-Recent-Developments-of-Subsidiary-ViralClear-and-its-BroadSpectrum-Oral-AntiViral-Candidate-Merimepodib-for-the-Treatment-of-COVID19

Vicromax (merimepodib) - BioSig Tech

remdesivir (GS-5734) - Gilead

http://www.globenewswire.com/news-release/2020/04/24/2021896/0/en/BioSig-to-Host-Conference-Call-on-Recent-Developments-of-Subsidiary-ViralClear-and-its-Broad-Spectrum-Oral-Anti-Viral-Candidate-Merimepodib-for-the-Treatment-of-COVID-19.html

Apr 24, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next